P33.17 Incidence of PD-L1 Expression at Clinically Significant Cut Offs in NSCLC EGFR Mutated Population Compared to Wild Type

MLA

Diana N. Ionescu, et al. “P33.17 Incidence of PD-L1 Expression at Clinically Significant Cut Offs in NSCLC EGFR Mutated Population Compared to Wild Type.” Journal of Thoracic Oncology, vol. 16, Mar. 2021, p. S412. EBSCOhost, https://doi.org/10.1016/j.jtho.2021.01.686.

APA

Diana N. Ionescu, C. Hughesman, Julia R. Naso, & B. Melosky. (2021). P33.17 Incidence of PD-L1 Expression at Clinically Significant Cut Offs in NSCLC EGFR Mutated Population Compared to Wild Type. Journal of Thoracic Oncology, 16, S412. https://doi.org/10.1016/j.jtho.2021.01.686

Chicago

Diana N. Ionescu, C. Hughesman, Julia R. Naso, and B. Melosky. 2021. “P33.17 Incidence of PD-L1 Expression at Clinically Significant Cut Offs in NSCLC EGFR Mutated Population Compared to Wild Type.” Journal of Thoracic Oncology 16 (March): S412. doi:10.1016/j.jtho.2021.01.686.